Dr. Li

Jonathan Li, MD, MMSc, is an Associate Professor of Medicine at Harvard Medical School, Brigham and Women’s Hospital. 

Dr. Li graduated magna cum laude from Brown University in 1999 with a Bachelor of Arts in Biology and Computer Science. He received his Medical Degree in 2004 from the University of California, San Francisco. In 2001, Dr. Li received the Vanderryn Memorial Fund Award for summer internship in Mexico City and the Rainer Fund International Health Travel Grant from the University of California, San Francisco.  Dr. Li received the Doris Duke Clinical Research Fellowship and studied the viral host features of HIV long-term survivors in China and evaluated the virucidal efficacy of soap and water on HIV in genital secretions from 2002-2003. 

Dr. Li completed his residency in Internal Medicine in 2007 at the University of California, San Francisco. During his residency program, Dr. Li was a recipient of the Floyd C. Rector Research Symposium Award, the Teaching Excellence Award for Cherished Housestaff and the Jeffrey Weingarten Award for Housestaff. 

Dr. Li continued his medical training as a Fellow in Infectious Disease at Massachusetts General Hospital, Brigham and Women’s Hospital, and a Research Fellow at Harvard Medical School from July 2007- June 2010. During his fellowship, Dr. Li was awarded both the Edward H. Kass Award for Clinical Excellence and the Maxwell Finland Award for Research Excellence by the Massachusetts Infectious Disease Society. 

Dr. Jonathan Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the NIH COVID-19 Treatment Guidelines Panel. He also holds leadership positions in the AIDS Clinical Trials Group (ACTG) as the the Director of the ACTG Virology Core Laboratories, a member of the ACTG HIV Reservoirs and Viral Eradication Transformative Science Group and as the Chair of several ACTG clinical trials. He has also served on the ACTG Executive Committee.

Dr. Li is an R01-funded investigator with a research focus on HIV and SARS-CoV-2 drug resistance, reservoirs, and viral evolution. Since joining the faculty at the Brigham and Women’s Hospital and Harvard Medical School, Dr. Li has published in high-impact journals such as the NEJMJAMAAnnals of Internal MedicineNature MicrobiologyJournal of Clinical Investigation, the Journal of Infectious Diseases, and Clinical Infectious Diseases. He is the Deputy Editor of the Journal of Infectious Diseases.

Dr. Li has also received a number of awards and honors. He is the recipient of the Young Investigator Award at the Conference on Retrovirus and Opportunistic Infections (CROI). In the spring of 2014, Dr. Li was awarded the John Carey Young Investigator Award by the ACTG. In 2022, he was elected to the American Society for Clinical Investigation. He is also the recipient of a Celebration of Science Recognition Award for a co-senior author paper presented by the MGH Executive Committee on Research.

During the course of his career, Dr. Li has trained many medical students, residents, and fellows in clinical settings, as well as undergraduate and graduate students, and post-doctoral fellows in the laboratory.  He is the Brigham and Women’s Hospital ID Fellowship Research Director. Dr. Li has also taught courses at Harvard Medical School to medical and MD/PhD students. Dr. Li regularly gives presentations at local, national and international conferences on his studies. In addition, Dr. Li sees patients in both the outpatient Infectious Diseases clinic and in the inpatient consult service at the Brigham and Women’s Hospital. He continues to split his time between the research lab, patient care, and teaching aspiring researchers in the HIV/AIDS and SARS-CoV-2 fields.